Pharmacogenomics (PGx) is transforming cardiovascular medicine by enabling personalized treatment approaches based on a patient’s genetic profile. In particular, PGx is helping cardiologists optimize the use of antiplatelet, anticoagulant, and beta-blocker therapies in patients with acute coronary syndrome (ACS) or undergoing percutaneous coronary intervention (PCI). While numerous critical aspects are involved in practical cardiovascular medicine […]